Trial Profile
Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 May 2022
Price :
$35
*
At a glance
- Drugs Nilotinib (Primary) ; Vinblastine
- Indications Glioma
- Focus Adverse reactions
- Acronyms Vinilo
- 24 May 2022 Status changed from recruiting to completed.
- 05 Oct 2021 This trial has been completed in Netherlands, according to European Clinical Trials Database record.
- 03 Nov 2020 This trial has been discontinued in Netherlands, according to European Clinical Trials Database record.